statistics between the full ENIGMA results (including patients) and a subset of ENIGMA results (excluding patients) showed that they were very highly correlated (Pearson's r > 0.99) for all brain traits (Hibar et al., 2015) Prior to the analyses here, we verified that there was no overlap between the cohorts included in the TS and brain volume GWASs. The brain volume GWAS data is comprised of separate GWASs of seven subcortical brain volumes (nucleus accumbens, amygdala, caudate nucleus, hippocampus, globus pallidus, putamen, thalamus) and total intracranial volume. GWAS test statistics were genome-controlled to adjust for spurious inflation factors. All cohort studies were approved by a local ethics board prior to subject recruitment and all subjects gave written, informed consent before participating.
Post-processing of genetic data
To statistically compare the TS and brain volume GWASs, we used the 7,682,991 SNPs that passed quality control and filtering rules in all datasets. With these data, we performed a clumping procedure in PLINK (Purcell et al., 2007) to identify an independent SNP from every linkage disequilibrium (LD) block across the genome. The clumping procedure was performed separately for each of the 8 brain volume GWASs using a 500 Kb window, with SNPs in LD (r 2 > 0.2), in the European reference samples from the 1000
Genome Project (Phase 1, version 3). The SNP with the lowest p-value within each LD block was selected as the index SNP representing that LD block and all other SNPs in the LD block were dropped from the analysis. The result after applying the clumping procedure was a total of 8 independent sets of SNPs representing the total variation explained across the genome conditioned on the significance in each brain volume GWAS. For each of these 8 sets of SNPs, we then determined the corresponding TS GWAS test statistic for each independent index SNP and used these datasets for the subsequent analyses.
Tests of pleiotropy and concordance
We used SNP Effect Concordance Analysis (SECA) (see Nyholt et al., 2014 for details of the SECA analysis) to test for genetic pleiotropy -the same SNP affecting two traits -and concordance -the agreement in SNP effect directions across these two traits -between TS, social disinhibition or symmetry behaviour and all 7 subcortical structures and ICV. Given the number of tests performed, we set a Bonferroni-corrected significance level at P* = 0.05/48 = 1,042x10 -3 to account for the 3 traits tested (TS, social disinhibition and symmetry behaviour), the 8 brain volumes and the two tests performed (SECA and LDSR).
Conditional false discovery rate to detect TS, social disinhibition or symmetry behaviour risk variants
We also examined if conditioning the results of the TS GWAS on genetic variants that influence brain volume could improve our ability to detect variants associated with TS (Sun et al., 2006; Andreassen et al., 2013) . At this sample size the analyses were underpowered to investigate the symptom dimensions separately. For a given brain volume phenotype, we selected subsets of SNPs at 14 false discovery rate
, 1x10 -3 , 0.01, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1) and looked up the corresponding p-values for each SNP subset in the TS GWAS and the social disinhibition and symmetry behaviour symptom clusters. Next we applied the FDR method (Benjamini and Hochberg, 1995) to each subset of p-values in the TS GWAS and the social disinhibition and symmetry behaviour symptom clusters. Individual SNPs were considered significant if the p-value was lower than the significance threshold allowing for a False Discovery Rate (FDR) of 5% conditioned on any subset of SNPs from the brain volume GWASs. The LD-pruned data are still required for the conditional FDR SNP analysis because regions with varying amounts of SNPs within an LD block can affect the ranking and re-ranking of SNPs under the conditional models. However, the chosen SNP included in the model is likely just a "proxy" for SNPs in the LD block and should not necessarily be considered a causal variant or even the most significant SNP in terms of its overlap between traits.
Estimating genetic correlation using LD score regression
In order to replicate significant findings from our primary analysis with SECA, we used an alternative method, LD score regression (LDSR), which estimates a genetic correlation between two trait pairs based on the GWAS summary statistics of each trait analysed separately (Bulik-Sullivan et al., 2015a , 2015b . LDSR estimates a genetic correlation with a fitted linear model of Z-scores obtained from the product of significance statistics for each SNP in a given set of GWAS results compared to the level of linkage disequilibrium at a given SNP. SNPs in high LD are expected to have high Z-scores in polygenic traits with common genetic overlap (Bulik-Sullivan et al., 2015a) . We used the ldsc program (https://github.com/bulik/ldsc) to perform LDSR following the methods outlined in Bulik-Sullivan et al.,
2015a. LDSR was underpowered at this sample size to analyse the amygdala, as well as the TS symptom clusters. Therefore, LDSR was only used to test for an association with the broader TS phenotype and the remaining 7 brain regions of interest.
RESULTS

Evidence for pleiotropy between brain volume and TS and related symptom cluster risk variants
We found significant evidence of global pleiotropy -same SNP, regardless of effect direction-between variants that infer risk for the broader TS phenotype and variants that are associated with lower putamen volumes ( Table 1, p=2x10 -4 ) and caudal volumes ( Table 1, p=4x10 -4 ). Further, we found nominally significant (p<0.05) evidence of pleiotropy between TS risk variants and variants associated with lower ICV, accumbens, and thalamus volumes and greater hippocampus volume ( Table 1) . No evidence for global pleiotropy was found for either the social disinhibition ( Table 2 ) or symmetry behaviour (Table 3 ) TS symptom clusters.
Evidence for concordance between brain volumes and TS and related symptom clusters risk variants
We found significant evidence of negative concordance -same SNP, same direction of effect -between TS and thalamic volume ( Table 1, p=3x10 -4 ), indicating an association between TS genetic risk and lower thalamic volume. Further, we found nominally significant (p<0.05) negative concordance between the ICV and caudate with TS ( Table 1) . Nominally significant positive concordance was found between the amygdala and TS. Significant negative concordance was also identified between the social disinhibition behaviour symptom cluster and the thalamus ( ) as well as marginally significant negative concordance with the accumbens (p=2.3x10 -3 ) and positive concordance with the pallidum (p=0.47x10
-2
).
Significant positive concordance was also identified between symmetry behaviour and putamen volume (Table 3 , p=7x10 -4 ). Further, evidence for marginally significant negative concordance between this symptom cluster and the amygdala (p=2x10 -3 ) and positive concordance with the caudate (p=1.7x10 -2 ) were identified.
Replication of subcortical brain volumes and TS genetic risk overlap using LDSC
Replication using LDSR lent trending support for an association between TS risk and the thalamus ( Table 4, p=5.85x10 -2 ). No association between TS and pallidum volume was observed using this technique.
Genetic variants influencing subcortical brain volumes provide improved ability to detect TS risk variants
We performed a conditional FDR analysis, conditioning the TS risk variants on each of the 8 brain volume GWAS (Table 5) . When conditioning the TS analysis on variants that influence ICV, rs2708146 (q=0.046) and rs72853320 (q=0.035) were significantly associated with both traits. Conditioning on the hippocampus also revealed an association between rs1922786 (q=0.001). No significant associations (q<0.05) were identified when conditioning TS on the other 6 brain GWAS.
DISCUSSION
Of the eight brain traits investigated using SECA, associations were found between genetic risk for TS and for lower thalamic, putaminal and caudal volumes. These analyses of the clinical TS phenotype were further supported by SECA findings using symptom-based phenotypes; there was a significant association between genetic risk for lower thalamic volume and for the social disinhibition symptom cluster as well as a significant association between genetic risk for greater putaminal volume and for the symmetry symptom cluster. Further, three SNPs were associated with both TS and the volumes of the hypothalamus and ICV.
Associations of genetic risk for TS with genetic risk for alterations in thalamic and striatal volumes is consistent with the emphasis of neuroanatomical models of TS on these structures (Jeffries et al., 2002; Berardelli et al., 2003) . The thalamus has widespread projections affecting many aspects of cognition and motor function (Shipp, 2004) , and is a target for deep brain stimulation in the treatment of refractory TS (Porta et al., 2009) . While greater thalamic volumes have been reported in TS (Greene et al., 2016; Miller et al., 2010) , lower thalamic volumes have been identified in paediatric patients with TS (Makki et al., 2008) .
The dorsal striatum is also involved in motor function (Marchand et al., 2008) , as well as various types of learning (Ell et al., 2006; Seger, 2005) , inhibitory control of action and reward systems (Villablanca, 2010).
Evidence for both greater (Ludolph et al., 2007; Roessner et al., 2011) and lower putaminal volumes (Peterson et al., 2003; Bloch et al., 2005; Greene et al., 2016) have been reported in both children and adults with TS, with lower putaminal volumes reported in TS with comorbid OCD (Peterson et al., 2003) . Lower caudal volumes in adults and children have been associated with TS (Peterson et al., 2003; Bloch et al., 2005) , which are particularly apparent in individuals with comorbid ADHD (Peterson et al., 2003) , and are associated with tic severity and OCD symptoms (Bloch et al., 2005) .
The three variants and associated with TS after conditioning on hypothalamic (rs1922786) and ICV (rs2708146 and rs72853320) volumes have not previously been associated with a particular phenotype.
rs2708146 and rs1922786 are intronic variants located within the long intergenic non-protein coding RNA 1122 (LINC01122) gene on chromosome 2 and rs72853320 is an intergenic variant closest to the RNA U1 small nuclear 88 pseudogene (RNU1-88P) on chromosome 6. To date, little is known about the function of these genes, which are expressed in a broad range of tissue types, including the brain (Ensembl:
https://www.ensembl.org/index.html, accessed on 5 April 2018). Other variants within LINC01122 have previously been associated with red blood cell count, mean corpuscular haemoglobin and mean corpuscular volume in a GWAS investigating 36 blood cell phenotypes among 173,480 participants from the UK Biobank (Astle et al., 2016) . This study identified a total of 2,706 variants associated with these phenotypes, located within or near genes that are involved in pathways that have been implicated in schizophrenia, autoimmune diseases and cardiovascular disorders. (Astle et al., 2016) . As little is known about the genes and variants identified in our study, additional replications and functional studies are needed.
The analyses here complement prior work on OCD, where we found significant concordance between OCD risk variants and variants that are related to greater putaminal volume (p=8.0 x 10 -4 ) (Hibar et al., 2018) . In addition, the CSTC has been implicated in both disorders (Berardelli et al., 2003; Rauch and Britton, 2010) .
Our previous study on OCD did, however, also identify significant concordance between greater nucleus accumbens volume and OCD and conditional FDR only revealed significant associations with OCD when conditioned on putaminal, amygdalar, and thalamic volumes (Hibar et al., 2018) . Differences between OCD and TS are consistent with genetic analyses which have emphasized that despite their relatedness, these conditions have different genetic architectures (Davis et al., 2013; Yu et al., 2015) . The findings here arguably support the proposal in the eleventh revision of the International Classification of Diseases (ICD-11) to classify TS both as a neurodevelopmental disorder and as an obsessive compulsive related disorder (OCRD) (Stein et al., 2016; Robertson, 2015) .
Several limitations of this work should be emphasized. First, the LDSR analysis only lends trending support for the association between the thalamus and TS. LDSC was further underpowered to perform all the tests between brain volume and TS. Validation in an even larger cohort is, therefore, still necessary. Second, the analysis could be biased if overlapping participants were present in the studies contributing to the consortia.
We verified that the cohorts as whole did not overlap and individual overlap is, therefore, likely to be minimal. Third, the ENIGMA GWASs of brain volumes contain cohorts with healthy controls as well as patients diagnosed with neuropsychiatric disorders (including anxiety, Alzheimer's disease, ADHD, major depression, bipolar disorder, epilepsy and schizophrenia), which may bias the interpretation of our findings and how they relate to TS. However, a direct comparison of the GWAS summary statistics between the full ENIGMA results (including patients) and a subset of ENIGMA results (excluding patients) showed that they were very highly correlated (r 2 > 0.99) for all brain traits (Hibar et al., 2015) . This suggests that the pattern of effects in the brain volume GWAS is not likely driven by disease status. Fourth, approximately half of the TS cohort also has comorbid OCD. It is possible that stronger and more specific associations may be revealed in a cohort with TS only. Fifth, the relationship between gene variants influencing brain volume and neuropsychiatric risk may be influenced by a range of confounders, including environmental factors such as stress and medication effects, which have effects on brain volume and disease risk independent of genetics. Discovering the pathway by which gene variants influencing brain volume also create risk for TS and its symptom clusters is therefore susceptible to influence by environmental factors, which might obscure genetic relationships. However, an endeavour to find the genetic overlap between brain volume and disorder risk using the largest datasets to date is still worthwhile as it can potentially provide insights into the disorders.
In conclusion, this study implicated genetic overlap between genetic variants influencing the volumes of the thalamus, putamen and caudate in TS and its symptom dimensions. Further, this study identified three SNPs associated with TS and volumes of the hypothalamus and ICV. Indeed, these data are the first to show an overlap between risk for genes for TS and for brain circuitry. The correlations with putaminal and thalamic volumes are consistent with a broad range of previous neuroimaging work. Emerging collaborations and consortia, such as ENIGMA-TS, aim to continue to increase sample size, which will enhance statistical power in future iterations of this analysis. Additional work focusing on a range of other methodologies to assess genetic overlap may also be useful, following along the lines of recent work in schizophrenia (Lee et al., 2016; Franke et al., 2016; Mufford et al., 2017) . Such studies have used partitioning-based heritability analysis (Yang et al., 2011) and conjunction analysis (Nichols et al., 2005) to identify genetic variants associated with both schizophrenia risk and altered brain volumes. These approaches may also be useful in future work on TS and its symptom dimensions. The chromosome (Chr) and base pair (BP) are given in h19b37 coordinates. The Effect in Brain and Effect in TS (Tourette's syndrome) are both given in terms of the effect allele (EA). The non-effect allele (NEA) is also shown. The allele frequency (Freq) corresponds to the effect allele. Tagging SNP corresponds to the most significant variant in a given LD block (if different from the SNP chosen based on clumping in the brain volume GWAS). LINC01122 = long intergenic non-protein coding RNA 1122, RNU1-88P = RNA, U1 small nuclear 88, pseudogene 
